Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Immunology: B-cell development in the gut.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Impact of Sativex(®) on quality of life and activities of daily living in patients with multiple sclerosis spasticity.
S1P signaling: new therapies and opportunities.
NLRP3 inflammasome is associated with the response to IFN-β in patients with multiple sclerosis.
Infectious mononucleosis.
Diffusivity signatures characterize trigeminal neuralgia associated with multiple sclerosis.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci.
Functional magnetic resonance imaging movers and shakers: Does subject-movement cause sampling bias?
Central nervous system aquaporin-4 autoimmunity presenting with an isolated cerebral abnormality.
Sox2 Sustains Recruitment of Oligodendrocyte Progenitor Cells following CNS Demyelination and Primes Them for Differentiation during Remyelination.
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation.
TET2 gene expression and 5-hydroxymethylcytosine level in multiple sclerosis peripheral blood cells.
Sphingolipids: important players in multiple sclerosis.
Sudden onset of sleep due to hypothalamic lesions in neuromyelitis optica spectrum disorder positive for anti-aquaporin-4 antibody.
Minocycline protects SH-SY5Y cells from 6-hydroxydopamine by inhibiting both caspase-dependent and -independent programmed cell death.
Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica.
Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
Consensus Recommendations for the Diagnosis and Treatment of Multiple Sclerosis The Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS).
Menarche increases relapse risk in pediatric multiple sclerosis.
Programming Hippocampal Neural Stem/Progenitor Cells into Oligodendrocytes Enhances Remyelination in the Adult Brain after Injury.
Disability and Fatigue Can Be Objectively Measured in Multiple Sclerosis.
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
A short and validated multiple sclerosis-specific health-related quality of life measurement for routine medical practice.

Pages